GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.7966
-0.0650 (-7.54%)
Sep 9, 2025, 10:01 AM - Market open
GTBP's stock price has decreased by -55.82% in the past year and price targets may not have had time to catch up.
GT Biopharma Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$11.00
Upside
+1,280.87%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +1,280.87% | Dec 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +18,730.03% | Aug 8, 2023 |
| EF Hutton | EF Hutton | Hold Reiterates $60 | Hold | Reiterates | $60 | +7,432.01% | Aug 7, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +18,730.03% | Jun 5, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +18,730.03% | May 17, 2023 |
| EF Hutton | EF Hutton | Hold Reiterates $60 | Hold | Reiterates | $60 | +7,432.01% | May 16, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +18,730.03% | Apr 3, 2023 |
| EF Hutton | EF Hutton | Hold Reiterates $60 | Hold | Reiterates | $60 | +7,432.01% | Mar 31, 2023 |
| EF Hutton | EF Hutton | Hold Initiates $60 | Hold | Initiates | $60 | +7,432.01% | Jan 5, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $750 → $150 | Strong Buy | Maintains | $750 → $150 | +18,730.03% | Sep 13, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $750 | Strong Buy | Initiates | $750 | +94,050.14% | May 24, 2021 |
| Roth Capital | Roth Capital | Strong Buy Initiates $750 | Strong Buy | Initiates | $750 | +94,050.14% | Mar 17, 2021 |